Travere Therapeutics (TVTX) Skyrockets to Fresh High as FDA Concerns on Drug Candidate Subside

We recently published AI Frenzy: 10 Stocks Crushing the Market, 6 Climb to Fresh Highs. Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the top performers on Wednesday. Travere Therapeutics, Inc. (NASDAQ:TVTX) soared to a new all-time high on Wednesday, as investors cheered the Food and Drug Administration’s (FDA) decision to cancel the creation of an advisory committee that would support the review of its drug application to treat focal segmental glomerulosclerosis (FSGS). During the session, Travere ...